• Tidak ada hasil yang ditemukan

SUPPLEMENTAL MATERIAL

N/A
N/A
Protected

Academic year: 2024

Membagikan "SUPPLEMENTAL MATERIAL"

Copied!
2
0
0

Teks penuh

(1)

Cohen et al, Right Colon Retroflexion and Adenoma Detection

1 SUPPLEMENTAL MATERIAL:

Supplemental Table 1: Article search terms by database Medline/Pubmed Search Terms:

“Colon”[Mesh] OR "Cecum"[Mesh] OR "Colonic Neoplasms"[Mesh] OR "Cecal Neoplasms"[mesh] OR "Colon, Ascending"[Mesh] OR right colon[tiab] OR ascending colon[tiab] OR cecum[tiab] OR caecum;[tiab] OR coecum[tiab] OR OR cecal[tiab] OR hepatic flexure*[tiab] OR right side[tiab] OR proximal colon[tiab] OR colon[tiab]

Embase Search Terms:

((retro NEXT/1 flex*):ab,ti OR retroflex*:ab,ti OR retroview:ab,ti) AND ('cecum cancer'/exp OR 'cecum'/exp OR 'ascending colon'/exp OR 'colon tumor'/exp OR

‘colon’:ab,ti OR 'right colon':ab,ti OR 'ascending colon':ab,ti OR cecum:ab,ti OR cecal:ab,ti OR 'hepatic flexture':ab,ti OR 'right side':ab,ti OR 'proximal colon':ab,ti)

Supplemental Table 2: Quality assessment score of studies included in the meta- analysis

Study 1 2 3 4 5 6 7 8 Total

Aadam 2013

1 0 1 1 1 1 1 1 7

Baumann 2009

0 0 1 1 1 0 1 1 5

Chandran 2015

0 1 1 1 1 1 1 1 7

Gaddam 2012

1 1 0 1 1 1 1 1 7

Harrison 2004

0 1 0 1 1 1 1 1 6

Hewett

2011 1 1 0 1 1 1 1 1 7

Kushnir 2015

1 1 0 1 1 1 1 1 7

Vargas 2015

0 1 1 1 1 1 1 1 7

(2)

Cohen et al, Right Colon Retroflexion and Adenoma Detection

2 Supplemental Figure 1: Study quality assessment tool

Selection:

Representativeness:

1. Was the spectrum of patients representative of the patients who will receive the test (colonoscopy with right colon retroflexion) in practice. (ie. Study includes adults undergoing screening/surveillance) **

a. Yes = 1, No = 0

2. Were the exlusion criteria clearly defined? **

b. Yes = 1, No = 0

3. Were consecutive patients enrolled in the study? * c. Yes = 1, No = 0

Ascertainment of exposure:

4. Was the definition of successful retroflexion described? * d. Yes = 1, No = 0

Comparability

5. Each subject undergoes a consecutive cross-over from non-exposed to exposed, therefore, no confounding exists in this design phase. *

a. All studies = 1 Outcome

Assessment of outcome*

6. Histology of polyp given: Yes = 1, No = 0 7. Success of retroflexion reported: Yes = 1, No = 0

8. Complications of colonoscopy with retroflexion reported: Yes = 1, No = 0

* Adapted from Newcastle-Ottawa Scale

** Adapted from QUADAS-2 Scale

If classification of quality measure was unclear, then score of 0 was designated.

A priori score for high quality studies designated >= 7. Less than 7 considered low quality.

Referensi

Dokumen terkait

Quality assessment tool used for evaluation of the included studies CRITERIA YES 2 points UNCLEAR/INDIRECTLY CALCULATED 1 point NO 0 points Objective Was the research

Supplemental Digital Appendix 1 Frequency Report: Use of AAMC Standardized Video Interview SVI Total Scores and Videos in the Selection Process for the ERAS 2018 Cycle, as Reported

Supplemental Table 1: Assessment of steroid toxicity 1 Growth retardation: height >2 standard deviations below normal according to Tanner et al* in the absence of other causes of

Supplemental Digital Content 1 legend: Blood samples used for antiretroviral drug testing were collected in HPTN 043 during the post- intervention assessment.. The time period for the

1 Table of Contents for the Supplemental Material Table S1: List of medications that affect drowsiness and cognition included in the study---2 Table S2: Number of participants, by

Supplemental Table 1: Association between genotype at CLDN14 SNPs n=482 and calcium excretion in 24-hour urine in 393 hypertensive patients.. SNPs starting with “21:” are not yet